• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拮抗剂格拉司琼在5-羟色胺3型受体配体结合位点的空间取向。

Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.

作者信息

Yan Dong, White Michael M

机构信息

Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102, USA.

出版信息

Mol Pharmacol. 2005 Aug;68(2):365-71. doi: 10.1124/mol.105.011957. Epub 2005 May 24.

DOI:10.1124/mol.105.011957
PMID:15914697
Abstract

The serotonin type 3 receptor (5-HT(3)R) is a member of the cys-loop ligand-gated ion channel (LGIC) superfamily. Like almost all membrane proteins, high-resolution structural data are unavailable for this class of receptors. We have taken advantage of the high degree of homology between LGICs and the acetylcholine binding protein (AChBP) from the freshwater snail Lymnea stagnalis, for which high-resolution structural data are available, to create a structural model for the extracellular (i.e., ligand-binding) domain of the 5-HT(3)R and to perform a series of ligand docking experiments to delineate the architecture of the ligand-binding site. Structural models were created using homology modeling with the AChBP as a template. Docking of the antagonist granisetron was carried out using a Lamarckian genetic algorithm to produce models of ligand-receptor complexes. Two energetically similar conformations of granisetron in the binding site were obtained from the docking simulations. In one model, the indazole ring of granisetron is near Trp90 and the tropane ring is near Arg92; in the other, the orientation is reversed. We used double-mutant cycle analysis to determine which of the two orientations is consistent with experimental data and found that the data are consistent with the model in which the indazole ring of granisetron interacts with Arg92 and the tropane ring interacts with Trp90. The combination of molecular modeling with double-mutant cycle analysis offers a powerful approach for the delineation of the architecture of the ligand-binding site.

摘要

5-羟色胺3型受体(5-HT(3)R)是半胱氨酸环配体门控离子通道(LGIC)超家族的成员。与几乎所有膜蛋白一样,这类受体尚无高分辨率结构数据。我们利用LGIC与淡水蜗牛椎实螺的乙酰胆碱结合蛋白(AChBP)之间的高度同源性(已有AChBP的高分辨率结构数据),构建了5-HT(3)R细胞外(即配体结合)结构域的结构模型,并进行了一系列配体对接实验以描绘配体结合位点的结构。以AChBP为模板,通过同源建模构建结构模型。使用拉马克遗传算法对拮抗剂格拉司琼进行对接,以生成配体-受体复合物模型。对接模拟得到了格拉司琼在结合位点的两种能量相似的构象。在一种模型中,格拉司琼的吲唑环靠近色氨酸90,托烷环靠近精氨酸92;在另一种模型中,方向相反。我们使用双突变循环分析来确定这两种方向中的哪一种与实验数据一致,结果发现数据与格拉司琼的吲唑环与精氨酸92相互作用、托烷环与色氨酸90相互作用的模型一致。分子建模与双突变循环分析相结合,为描绘配体结合位点的结构提供了一种强大的方法。

相似文献

1
Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.拮抗剂格拉司琼在5-羟色胺3型受体配体结合位点的空间取向。
Mol Pharmacol. 2005 Aug;68(2):365-71. doi: 10.1124/mol.105.011957. Epub 2005 May 24.
2
The binding orientations of structurally-related ligands can differ; A cautionary note.结构相关配体的结合方向可能不同;一则警示说明。
Neuropharmacology. 2017 Jun;119:48-61. doi: 10.1016/j.neuropharm.2017.01.023. Epub 2017 Jan 27.
3
Mapping the Orthosteric Binding Site of the Human 5-HT Receptor Using Photo-cross-linking Antagonists.利用光交联拮抗剂绘制人 5-HT 受体的变构结合位点。
ACS Chem Neurosci. 2019 Jan 16;10(1):438-450. doi: 10.1021/acschemneuro.8b00327. Epub 2018 Sep 11.
4
Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.利用建模和放射性配体结合在5-羟色胺3受体结合位点定位拮抗剂。
J Biol Chem. 2005 May 27;280(21):20476-82. doi: 10.1074/jbc.M413610200. Epub 2005 Mar 21.
5
Structural basis of ligand recognition in 5-HT3 receptors.5-HT3 受体配体识别的结构基础。
EMBO Rep. 2013 Jan;14(1):49-56. doi: 10.1038/embor.2012.189. Epub 2012 Nov 30.
6
Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.激动剂和拮抗剂从5-羟色胺3受体的解离途径。
Biophys J. 2006 Mar 15;90(6):1979-91. doi: 10.1529/biophysj.105.069385. Epub 2005 Dec 30.
7
Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.同源和异源五聚体 5-HT3 受体配体识别位点的计算分析。
Eur J Med Chem. 2010 Nov;45(11):4746-60. doi: 10.1016/j.ejmech.2010.07.039. Epub 2010 Jul 27.
8
Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.利用分子标尺绘制 5-HT3 受体配体结合域中残基之间的空间关系图。
Biophys J. 2010 May 19;98(9):1847-55. doi: 10.1016/j.bpj.2010.01.034.
9
Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.通过非天然氨基酸诱变确定昂丹司琼和格拉司琼在5-羟色胺(3)受体中的结合方向。
ACS Chem Biol. 2012 Oct 19;7(10):1738-45. doi: 10.1021/cb300246j. Epub 2012 Aug 15.
10
Interactions of granisetron with an agonist-free 5-HT3A receptor model.格拉司琼与无激动剂的5-HT3A受体模型的相互作用。
Biochemistry. 2006 Jan 31;45(4):1099-105. doi: 10.1021/bi051676f.

引用本文的文献

1
Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa.后生动物 5-羟色胺 3(5-HT3)受体的系统发生分析。
PLoS One. 2023 Mar 1;18(3):e0281507. doi: 10.1371/journal.pone.0281507. eCollection 2023.
2
Molecular mechanism of setron-mediated inhibition of full-length 5-HT receptor.赛洛特介导的全长 5-HT 受体抑制的分子机制。
Nat Commun. 2019 Jul 19;10(1):3225. doi: 10.1038/s41467-019-11142-8.
3
The binding orientations of structurally-related ligands can differ; A cautionary note.结构相关配体的结合方向可能不同;一则警示说明。
Neuropharmacology. 2017 Jun;119:48-61. doi: 10.1016/j.neuropharm.2017.01.023. Epub 2017 Jan 27.
4
A Structural Model of the Human α7 Nicotinic Receptor in an Open Conformation.处于开放构象的人类α7烟碱型受体的结构模型。
PLoS One. 2015 Jul 24;10(7):e0133011. doi: 10.1371/journal.pone.0133011. eCollection 2015.
5
The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.一种在5-HT3A和5-HT3AB受体上具有独特性质的新型放射性配体的结合特性与取向。
Neuropharmacology. 2014 Nov;86:378-88. doi: 10.1016/j.neuropharm.2014.08.008. Epub 2014 Aug 28.
6
Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands.基于喹喔啉的 5-HT3A 和 5-HT3AB 受体选择性配体的结构-活性关系。
ChemMedChem. 2013 Jun;8(6):946-55. doi: 10.1002/cmdc.201300032. Epub 2013 May 2.
7
Discriminating between 5-HT₃A and 5-HT₃AB receptors.区分 5-HT₃A 和 5-HT₃AB 受体。
Br J Pharmacol. 2013 Jun;169(4):736-47. doi: 10.1111/bph.12166.
8
5-HT(3) receptors.5-羟色胺(3)受体。
J Biol Chem. 2012 Nov 23;287(48):40239-45. doi: 10.1074/jbc.R112.406496. Epub 2012 Oct 4.
9
Design, synthesis, and structure-activity relationships of highly potent 5-HT₃ receptor ligands.设计、合成和高活性 5-羟色胺 3 受体配体的构效关系研究。
J Med Chem. 2012 Oct 25;55(20):8603-14. doi: 10.1021/jm300801u. Epub 2012 Oct 12.
10
Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.通过非天然氨基酸诱变确定昂丹司琼和格拉司琼在5-羟色胺(3)受体中的结合方向。
ACS Chem Biol. 2012 Oct 19;7(10):1738-45. doi: 10.1021/cb300246j. Epub 2012 Aug 15.